194 related articles for article (PubMed ID: 30068316)
1. A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease.
Haeussler K; den Hout AV; Baio G
BMC Med Res Methodol; 2018 Aug; 18(1):82. PubMed ID: 30068316
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.
Haeussler K; Marcellusi A; Mennini FS; Favato G; Picardo M; Garganese G; Bononi M; Costa S; Scambia G; Zweifel P; Capone A; Baio G
Value Health; 2015 Dec; 18(8):956-68. PubMed ID: 26686779
[TBL] [Abstract][Full Text] [Related]
3. Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.
Dodd PJ; Pennington JJ; Bronner Murrison L; Dowdy DW
Med Decis Making; 2018 Nov; 38(8):930-941. PubMed ID: 30403578
[TBL] [Abstract][Full Text] [Related]
4. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling.
Spiegelhalter DJ; Best NG
Stat Med; 2003 Dec; 22(23):3687-709. PubMed ID: 14652869
[TBL] [Abstract][Full Text] [Related]
5. Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches.
Taylor DC; Pawar V; Kruzikas DT; Gilmore KE; Sanon M; Weinstein MC
Pharmacoeconomics; 2012 Feb; 30(2):119-26. PubMed ID: 22149631
[TBL] [Abstract][Full Text] [Related]
6. Health economic and infectious disease modelling: a guide to merging streams.
Anonychuk A; Krahn M
Pharmacoeconomics; 2011 May; 29(5):367-9. PubMed ID: 21504238
[No Abstract] [Full Text] [Related]
7. Use of Bayesian Markov chain Monte Carlo methods to estimate EQ-5D utility scores from EORTC QLQ data in myeloma for use in cost-effectiveness analysis.
Kharroubi SA; Edlin R; Meads D; Browne C; Brown J; McCabe C
Med Decis Making; 2015 Apr; 35(3):351-60. PubMed ID: 25784746
[TBL] [Abstract][Full Text] [Related]
8. Incorporating Contact Network Uncertainty in Individual Level Models of Infectious Disease using Approximate Bayesian Computation.
Almutiry W; Deardon R
Int J Biostat; 2019 Dec; 16(1):. PubMed ID: 31812945
[TBL] [Abstract][Full Text] [Related]
9. A choice that matters? Smulation study on the impact of direct meta-analysis methods on health economic outcomes.
Vemer P; Al MJ; Oppe M; Rutten-van Mölken MP
Pharmacoeconomics; 2013 Aug; 31(8):719-30. PubMed ID: 23736971
[TBL] [Abstract][Full Text] [Related]
10. Adaptive Markov chain Monte Carlo forward projection for statistical analysis in epidemic modelling of human papillomavirus.
Korostil IA; Peters GW; Cornebise J; Regan DG
Stat Med; 2013 May; 32(11):1917-53. PubMed ID: 22961869
[TBL] [Abstract][Full Text] [Related]
11. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
Cooper NJ; Sutton AJ; Abrams KR
Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
[TBL] [Abstract][Full Text] [Related]
12. Bayesian calibration of process-based forest models: bridging the gap between models and data.
Van Oijen M; Rougier J; Smith R
Tree Physiol; 2005 Jul; 25(7):915-27. PubMed ID: 15870058
[TBL] [Abstract][Full Text] [Related]
13. Bayesian Solutions for Handling Uncertainty in Survival Extrapolation.
Negrín MA; Nam J; Briggs AH
Med Decis Making; 2017 May; 37(4):367-376. PubMed ID: 27281336
[TBL] [Abstract][Full Text] [Related]
14. Hamiltonian Monte Carlo methods for efficient parameter estimation in steady state dynamical systems.
Kramer A; Calderhead B; Radde N
BMC Bioinformatics; 2014 Jul; 15(1):253. PubMed ID: 25066046
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian model averaging approach with non-informative priors for cost-effectiveness analyses.
Conigliani C
Stat Med; 2010 Jul; 29(16):1696-709. PubMed ID: 20572119
[TBL] [Abstract][Full Text] [Related]
16. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian hierarchical approach to account for evidence and uncertainty in the modeling of infectious diseases: An application to COVID-19.
Rehms R; Ellenbach N; Rehfuess E; Burns J; Mansmann U; Hoffmann S
Biom J; 2024 Jan; 66(1):e2200341. PubMed ID: 38285407
[TBL] [Abstract][Full Text] [Related]
18. Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model.
Nguyen CM; Bounthavong M; Mendes MA; Christopher ML; Tran JN; Kazerooni R; Morreale AP
Pharmacoeconomics; 2012 Jul; 30(7):575-93. PubMed ID: 22640174
[TBL] [Abstract][Full Text] [Related]
19. Estimation of Ordinary Differential Equation Models for Gene Regulatory Networks Through Data Cloning.
Son D; Kim J
J Comput Biol; 2023 May; 30(5):609-618. PubMed ID: 36898058
[TBL] [Abstract][Full Text] [Related]
20. A Probabilistic Framework for Molecular Network Structure Inference by Means of Mechanistic Modeling.
Timonen J; Mannerstrom H; Lahdesmaki H; Intosalmi J
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1843-1854. PubMed ID: 29993837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
